Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors

Completed · Not applicable

Conditions studied: Lung Cancer

In brief

The purpose of this research study is to determine if Stereotactic Body Radiation Therapy(SBRT) is a good way to treat tumors near the thorax. Stereotactic Body Radiation Therapy (SBRT) is a general term for a group of techniques that are designed to deliver radiation therapy in a way that damages normal tissues less than conventional radiotherapy. The two features that distinguish SBRT from conventional therapy are procedures that decrease errors in patient positioning and technology that results in a radiation dose distribution that conforms more tightly to the tumor target. Patients will receive either 48 Gy or 60 Gy fractions depending on the type of tumor. The majority of patients will be treated in 1 week, Monday through Friday, with Wednesday off.

Key facts

Study ID

NCT00632281

Run by

University of Florida

People needed

38

Starts

2006-01-01

Expected to finish

2008-11-01

Last updated by the study team

2012-02-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Informed consent to participate in this protocol
• Patients of all ages are eligible
• All tumor types are eligible
• Patients with prior thoracic radiotherapy and/or surgery are eligible
• Tumor size ≤ 5 cm

You may not qualify if…

• The subject is eligible for surgical resection or prefers treatment on this protocol to surgical resection.
• Less than 1 year since original radiation to thorax for retreatment patients.
• More than 2 tumors requiring SBRT
• The patient cannot be positioned reproducibly due to pain or other factors

Where it is running

• University of Florida Shands Cancer Center — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.